| 000 | 01832 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515230224.0 | ||
| 264 | 0 | _c20110119 | |
| 008 | 201101s 0 0 eng d | ||
| 022 | _a1469-8749 | ||
| 024 | 7 |
_a10.1111/j.1469-8749.2010.03717.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGutierrez, Jose | |
| 245 | 0 | 0 |
_aSubacute sclerosing panencephalitis: an update. _h[electronic resource] |
| 260 |
_bDevelopmental medicine and child neurology _cOct 2010 |
||
| 300 |
_a901-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Viral _xisolation & purification |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 |
_aDemyelinating Diseases _xvirology |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aElectroencephalography |
| 650 | 0 | 4 |
_aEpilepsies, Myoclonic _xvirology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGliosis _xvirology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInosine Pranobex _xtherapeutic use |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeasles _xcomplications |
| 650 | 0 | 4 |
_aMeasles Vaccine _xadministration & dosage |
| 650 | 0 | 4 |
_aMeasles virus _ximmunology |
| 650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 |
_aSubacute Sclerosing Panencephalitis _xcerebrospinal fluid |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVirion _xdrug effects |
| 700 | 1 | _aIssacson, Richard S | |
| 700 | 1 | _aKoppel, Barbara S | |
| 773 | 0 |
_tDevelopmental medicine and child neurology _gvol. 52 _gno. 10 _gp. 901-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1469-8749.2010.03717.x _zAvailable from publisher's website |
| 999 |
_c19909836 _d19909836 |
||